Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
99mTc-SSS Lipiodol UltraFluid
- Development stage
- Unknown
- Lead developer
- Centre Eugene Marquis
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intra-arterial
01
Overview
**99mTc-SSS Lipiodol UltraFluid** is an investigational technetium-99m radiolabeled iodized-oil preparation developed as a biodistribution and potential pretherapeutic imaging surrogate for radiolabeled Lipiodol-based intra-arterial therapy of hepatocellular carcinoma. It consists of a lipophilic technetium-99m Super Six Sulfur complex dissolved in Lipiodol UltraFluid, an iodized poppy-seed oil. Following hepatic arterial administration, the oily radiotracer preferentially deposits in hypervascular liver tumors and can be measured by gamma imaging or gamma counting. In rat hepatocellular carcinoma experiments, stabilized water-in-oil and oil-in-water emulsions of this agent did not improve tumor targeting and instead reduced tumor uptake in several tested formulations.
- Other names
- 99mTc-SSS LUF99mTc-SSS Lipiodol99mTc-SSS-lipiodoltechnetium Tc 99m-labeled Super Six Sulfur Lipiodol UltraFluid
Beyond the preview
Go deeper on 99mTc-SSS Lipiodol UltraFluid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 99mTc-SSS Lipiodol UltraFluid.